ZoomRx Launched AI-Powered Marketing Testing Application
The new tool accelerates biopharma messaging studies from months to approximately one week.
Updated on Oct. 13, 2026 in Advertising
Live Poll
Do you trust AI-driven automation to effectively optimize marketing strategies for your business?
ZoomRx has introduced Marketing Asset Testing, an AI-driven platform designed to evaluate pharmaceutical advertising materials. The application leverages synthetic data and a massive panel of healthcare professionals to provide rapid feedback to brand teams.
Why it matters
Traditional messaging studies often take up to 12 weeks, which is frequently too slow for the fast-paced marketing requirements of modern biopharma brands. This tool allows companies to evaluate a higher volume of creative assets than manual research processes historically permitted.
The platform reduces study setup to between 1 and 2 days, with fieldwork completed in 5 to 7 days. This service is backed by a proprietary panel of over 65,000 healthcare professionals and patients.
The players
ZoomRx
This life sciences research firm serves over 100 biopharma companies, including 19 of the top 20 global leaders in the industry.
The details
The application uses AI agents to manage study design, survey creation, and quality checks before final brand approval. It pulls from a database of more than 700 million proprietary benchmark data points to inform its analysis.
Timeline
ZoomRx announced the launch of Marketing Asset Testing on October 13, 2026.
The company is offering a free pilot for its Sagan Agents platform through December 31, 2026.
Market Landscape
This development reflects the broader industry shift toward integrating generative AI to automate labor-intensive research and development processes. It positions ZoomRx to capture greater market share by addressing the efficiency bottlenecks faced by global biopharma teams.
For employees at biopharma firms, this technology enables faster iteration and testing of marketing creative without the typical delays associated with manual research. Marketing teams can now receive study results just one day after fieldwork concludes, significantly speeding up decision-making cycles.
The takeaway
The integration of synthetic data in market research is drastically shrinking timelines for pharmaceutical advertising teams. Companies looking to remain competitive should evaluate whether their current manual research workflows are creating unnecessary delays in their brand strategies.
What happens next
The free pilot program for the Sagan Agents platform will conclude on December 31, 2026.
Further reading
Learn more about the latest trends in industry campaigns in our Advertising section.
More information
Interested firms can sign up for the free Sagan Agents pilot registration on the company website.
Live Poll
Do you trust AI-driven automation to effectively optimize marketing strategies for your business?
